156 related articles for article (PubMed ID: 26046433)
1. It's a SMAD/SMAD World.
Taniguchi C; Maitra A
Cell; 2015 Jun; 161(6):1245-6. PubMed ID: 26046433
[TBL] [Abstract][Full Text] [Related]
2. RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.
Whittle MC; Izeradjene K; Rani PG; Feng L; Carlson MA; DelGiorno KE; Wood LD; Goggins M; Hruban RH; Chang AE; Calses P; Thorsen SM; Hingorani SR
Cell; 2015 Jun; 161(6):1345-60. PubMed ID: 26004068
[TBL] [Abstract][Full Text] [Related]
3. RUNX3 Modulates Metastatic Potential in Pancreatic Ductal Adenocarcinoma.
Cancer Discov; 2015 Jul; 5(7):OF27. PubMed ID: 26045017
[TBL] [Abstract][Full Text] [Related]
4. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
[TBL] [Abstract][Full Text] [Related]
7. Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma.
Jian Z; Cheng T; Zhang Z; Raulefs S; Shi K; Steiger K; Maeritz N; Kleigrewe K; Hofmann T; Benitz S; Bruns P; Lamp D; Jastroch M; Akkan J; Jäger C; Huang P; Nie S; Shen S; Zou X; Ceyhan GO; Michalski CW; Friess H; Kleeff J; Kong B
Cell Mol Gastroenterol Hepatol; 2018; 6(4):429-449. PubMed ID: 30258965
[TBL] [Abstract][Full Text] [Related]
8. RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer.
Rossi E; Bagalà C; Inzani F; Leoncini E; Brunelli C; Lanza P; Basso M; Mattiucci GC; Cassano A; Rindi G; Barone C; Schinzari G
In Vivo; 2017; 31(5):833-840. PubMed ID: 28882948
[TBL] [Abstract][Full Text] [Related]
9. DPC4 gene expression in primary pancreatic ductal adenocarcinoma: relationship with CT characteristics.
Choi SH; Kim HJ; Kim KW; An S; Hong SM; Kim SC; Kim MH
Br J Radiol; 2017 May; 90(1073):20160403. PubMed ID: 28339284
[TBL] [Abstract][Full Text] [Related]
10. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL
Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891
[TBL] [Abstract][Full Text] [Related]
11. Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas.
Handra-Luca A; Hammel P; Sauvanet A; Ruszniewski P; Couvelard A
J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):294-302. PubMed ID: 22581056
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
13. The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinoma.
Sunamura M; Lefter LP; Duda DG; Morita R; Inoue H; Yokoyama T; Yatsuoka T; Abe T; Egawa S; Furukawa T; Fukushige S; Oshimura M; Horii A; Matsuno S
Pancreas; 2004 Apr; 28(3):311-6. PubMed ID: 15084978
[TBL] [Abstract][Full Text] [Related]
14. Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice.
Xu X; Ehdaie B; Ohara N; Yoshino T; Deng CX
Oncogene; 2010 Feb; 29(5):674-86. PubMed ID: 19901970
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic Cancer: Planning Ahead for Metastatic Spread.
Stromnes IM; Greenberg PD
Cancer Cell; 2016 Jun; 29(6):774-776. PubMed ID: 27300430
[TBL] [Abstract][Full Text] [Related]
16. DPC4/Smad4 protein is highly expressed in intraductal papillary-mucinous neoplasms.
Kume K; Suda K; Nobukawa B; Sonoue H
Histopathology; 2006 Jun; 48(7):874-6. PubMed ID: 16722941
[No Abstract] [Full Text] [Related]
17. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
19. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
20. The dissociated expression of protein and messenger RNA of DPC4 in human invasive ductal carcinoma of the pancreas and their implication for patient outcome.
Toga T; Nio Y; Hashimoto K; Higami T; Maruyama R
Anticancer Res; 2004; 24(2C):1173-8. PubMed ID: 15154643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]